SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the month of December 2022
Commission File Number 001-40316
VECTIVBIO HOLDING AG
(Exact name of registrant as specified in its charter)
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Resignation of Director
On December 27, 2022, Chahra Louafi submitted her resignation from the Board of Directors of VectivBio Holding AG (the Company), which resignation was effective immediately. Ms. Louafis resignation was not the result of any disagreement with the Company.
Incorporation by Reference
The Company hereby incorporates by reference the information contained in the body of this Report on Form 6-K into the Companys registration statements on Form S-8 (File No. 333-255524) and Form F-3 (File Nos. 333-264653 and 333-265546) (including any prospectuses forming a part of such registration statements) and deems them to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|VECTIVBIO HOLDING AG|
|December 30, 2022||By:|
|Chief Executive Officer|